Valuation : AstraZeneca PLC

Market Cap 25TCr 22TCr 20TCr 19TCr 35TCr 23,77300Cr 35TCr 2,40900Cr 93TCr 12,19700Cr 95TCr 92TCr 39,29300Cr P/E 2026 *
20.9x
P/E 2027 * 18.3x
Enterprise Value 27TCr 23TCr 22TCr 20TCr 38TCr 25,61000Cr 38TCr 2,59500Cr 1,00700Cr 13,14000Cr 1,01900Cr 1LCr 42,33000Cr EV / Sales 2026 *
4.29x
EV / Sales 2027 * 3.94x
Free-Float
96.63%
Yield 2026 *
2.06%
Yield 2027 * 2.19%
1 day+1.78%
1 week+1.25%
Current month+1.25%
1 month+4.25%
3 months-8.97%
6 months-11.22%
Current year-7.07%
1 week 1,513.5
Extreme 1513.5
1,587.5
1 month 1,470.5
Extreme 1470.5
1,612
Current year 1,467
Extreme 1467
1,925.5
1 year 1,365
Extreme 1365
1,925.5
3 years 1,226
Extreme 1226
1,925.5
5 years 960.3
Extreme 960.3
1,925.5
10 years 461.3
Extreme 461.3
1,925.5
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.74%+1.25% - - 25TCr
-0.88%-2.15%+58.05%+105.26% 1,02400Cr
-1.15%+2.68%+54.25%+74.19% 66TCr
-1.44%+0.38%+20.65%+76.13% 45TCr
-0.66%+0.57%+31.36%+38.24% 35TCr
-2.65%+2.43%+23.40%+42.46% 30TCr
+1.42%+1.82%+1.75%+12.53% 25TCr
-1.55%+1.11%+54.15%+75.59% 24TCr
-0.13%+1.95%-14.08%-55.92% 21TCr
-0.15%+3.65%+31.24%+103.39% 19TCr
Average -0.53%+1.26%+28.98%+52.43% 40.87TCr
Weighted average by Cap. -0.75%+0.62%+37.84%+67.10%

Financials

2026 *2027 *
Net sales 6.33TCr 5.45TCr 5.12TCr 4.68TCr 8.76TCr 5,97500Cr 8.78TCr 61TCr 23TCr 3,06500Cr 24TCr 23TCr 9,87500Cr 6.69TCr 5.75TCr 5.41TCr 4.95TCr 9.25TCr 6,31300Cr 9.28TCr 64TCr 25TCr 3,23900Cr 25TCr 25TCr 10,43500Cr
Net income 1.2TCr 1.03TCr 972.98Cr 888.82Cr 1.66TCr 1,13500Cr 1.67TCr 11TCr 4.46TCr 58TCr 4.51TCr 4.41TCr 1,87500Cr 1.37TCr 1.18TCr 1.11TCr 1.01TCr 1.9TCr 1,29400Cr 1.9TCr 13TCr 5.09TCr 66TCr 5.14TCr 5.03TCr 2,13800Cr
Net Debt 1.95TCr 1.67TCr 1.58TCr 1.44TCr 2.69TCr 1,83800Cr 2.7TCr 19TCr 7.23TCr 94TCr 7.31TCr 7.15TCr 3,03700Cr 1.18TCr 1.01TCr 954.4Cr 871.84Cr 1.63TCr 1,11300Cr 1.64TCr 11TCr 4.38TCr 57TCr 4.43TCr 4.33TCr 1,84000Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
07/26/07 SEK 1,583.00 +1.77% 3,70,938
04/26/04 SEK 1,555.50 -0.96% 5,44,344
03/26/03 SEK 1,570.50 +0.64% 5,02,662
02/26/02 SEK 1,560.50 +0.32% 5,94,091
01/26/01 SEK 1,555.50 -0.51% 7,42,928
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
162.34USD
Average target price
212.94USD
Spread / Average Target
+31.17%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!